| scholarly article | Q13442814 |
| P2093 | author name string | Wei Wang | |
| Charlie Xiang | |||
| Bingyu Xiang | |||
| Fanlong Liu | |||
| Xiaozhou Mou | |||
| P2860 | cites work | Gene therapy for brain tumors: basic developments and clinical implementation | Q26829086 |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice | Q28115905 | ||
| mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic | Q28204896 | ||
| FLT3: receptor and ligand | Q28272029 | ||
| The role of ephrins and Eph receptors in cancer | Q28294851 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 | ||
| Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. | Q33514643 | ||
| Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium | Q33907615 | ||
| Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma | Q33930115 | ||
| The development of neural stem cells | Q34100159 | ||
| Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594. | Q34198924 | ||
| Suicide gene therapy in cancer: where do we stand now? | Q34277497 | ||
| Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma. | Q34343768 | ||
| Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. | Q34359268 | ||
| Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression | Q34369804 | ||
| Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma | Q34480527 | ||
| Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression. | Q34546483 | ||
| Plasticity of human menstrual blood stem cells derived from the endometrium | Q34919214 | ||
| Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation | Q35128063 | ||
| mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine | Q35609031 | ||
| Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12 | Q35943736 | ||
| Mesenchymal stem cells engineered for cancer therapy | Q36092724 | ||
| Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. | Q36097429 | ||
| Is mda-7/IL-24 a "magic bullet" for cancer? | Q36313094 | ||
| Gene therapy: can neural stem cells deliver? | Q36350210 | ||
| The chemokine network: a target in cancer biology? | Q36601660 | ||
| VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma | Q36858190 | ||
| Interleukin-12: biological properties and clinical application | Q36910729 | ||
| Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? | Q37029367 | ||
| Glioblastoma in adults | Q37131407 | ||
| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 | ||
| Immunosuppression by mesenchymal stromal cells: from culture to clinic | Q37161675 | ||
| The role of microglia in central nervous system immunity and glioma immunology | Q37206898 | ||
| Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells | Q37312922 | ||
| Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. | Q37411957 | ||
| Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma | Q37579001 | ||
| Future prospects and challenges of antiangiogenic cancer gene therapy | Q37693907 | ||
| Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine | Q37838867 | ||
| Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 | ||
| Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach? | Q37895369 | ||
| The neurobiology of gliomas: from cell biology to the development of therapeutic approaches | Q37910730 | ||
| Cancer immunoediting in malignant glioma | Q37986999 | ||
| Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma | Q38888896 | ||
| Glioma gene therapy using induced pluripotent stem cell derived neural stem cells | Q39166287 | ||
| Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 | ||
| Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells | Q39472529 | ||
| Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma | Q39512141 | ||
| Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma | Q39750216 | ||
| Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery | Q39856747 | ||
| Identification of gliotropic factors that induce human stem cell migration to malignant tumor | Q39863377 | ||
| Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 | ||
| Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy | Q40110233 | ||
| BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis | Q40243264 | ||
| Cancer gene therapy using a novel secretable trimeric TRAIL. | Q40367155 | ||
| The secretable form of trimeric TRAIL, a potent inducer of apoptosis | Q40517357 | ||
| The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. | Q40726417 | ||
| Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. | Q41115802 | ||
| Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. | Q43115465 | ||
| Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties | Q43796887 | ||
| A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. | Q45739549 | ||
| Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells | Q45866586 | ||
| Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection | Q45881014 | ||
| Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites | Q48323822 | ||
| Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 | ||
| Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates | Q48444277 | ||
| Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma | Q48506538 | ||
| Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells | Q48587406 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. | Q53403935 | ||
| Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. | Q53538261 | ||
| An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin. | Q54643813 | ||
| Gene therapy and targeted toxins for glioma | Q57006162 | ||
| Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study | Q64379100 | ||
| A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells | Q64379556 | ||
| Menstrual blood stromal cells: the potential for regenerative medicine | Q81547261 | ||
| A fresh look at iPS cells | Q83608099 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | 17102-9 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Stem cells as cellular vehicles for gene therapy against glioblastoma | |
| P478 | volume | 8 |
Search more.